Levita Magnetics Secures $26M To Advance Disruptive Surgical Robotic System

Aug 11, 2022•almost 3 years ago

Amount Raised

$26 Million

Menlo ParkMedical DeviceMedicalBiotechnologyHealth CareManufacturing

Description

Levita Magnetics, on a mission to provide patients with more access to better surgery, today announced the closing of its $26 million Series C financing, which will be used to support regulatory and near-term commercial efforts in the United States for its Magnetic-Assisted Robotic Surgery (MARS) platform. The financing was led by a healthtech investment group managed by seasoned investor Evan Norton, with participation from MedTex Ventures, as well as Invermaster and Carao Ventures, amongst other returning investors. The company also announced the appointment of Maria Sainz as chairwoman to its board of directors.

Company Information

Company

Levita Magnetics International Corp.

Location

4055A CAMPBELL AVE

Menlo Park, California, United States

About

The Levita Magnetic-Assisted Robotic Surgery (MARS) Platform is designed to improve the efficiency and quality of procedures in high-volume abdominal surgeries, improving surgical access to patients and enabling a less invasive approach with fewer incisions, while allowing the surgeon full control of the platform and surgical instruments directly beside the patient. The MARS Platform is an investigational system. It is not available for commercial sale in the United States and has not been cleared by the Food and Drug Administration (FDA).

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Levita Magnetics Secures $26M To Advance Disruptive Surgical Robotic System

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information